EUVIMEDEUVIMED entdecken
Crossref

Mangiferin attenuates osteoporosis by inhibiting osteoblastic ferroptosis through Keap1/Nrf2/SLC7A11/GPX4 pathway

Xuehui Deng, Bingfeng Lin, Fang Wang, Pingcui Xu, Nani Wang

Phytomedicine · 2024-02 · 124 · 155282

DOI: 10.1016/j.phymed.2023.155282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024-02. Verfasst von Xuehui Deng und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 311402, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Ferroptosis, Xanthones. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ferroptosis is a crucial contributor to impaired osteoblast function in osteoporosis. Mangiferin, a xanthonoid glucoside isolated from mangoes, exhibits anti-osteoporosis effects. However, its potential mechanism is not fully understood. PURPOSE: This study explores the potencies of mangiferin on osteoblastic ferroptosis and deciphers its direct target in the context of solute carrier family 7-member 11 (SLC7A11)/glutathione peroxidases 4 (GPX4) pathway. METHODS: In vivo models include bilateral ovariectomy induced osteoporosis mice, iron-dextran induced iron-overloaded mice, and nuclear factor-erythroid 2-related factor 2 (Nrf2)-knockout mice. Mice are orally administrated mangiferin (10, 50 or 100 mg.kg-1.d-1) for 12 weeks. In vitro osteoblast models include iron-dextran induced iron-overloaded cells, erastin induced ferroptosis cells, and gene knockout cells. RNA sequencing is applied for investigating the underlying mechanisms. The direct target of mangiferin is studied using a cellular thermal shift assay, silico docking, and surface plasmon resonance. RESULTS: Mangiferin promotes bone formation and inhibits ferroptosis in vivo models (osteoporosis mice, iron-overloaded mice) and in vitro models (ferroptosis osteoblast, iron-overloaded osteoblasts). Mechanismly, mangiferin directly binds to the kelch-like ECH-associated protein 1 (Keap1) and activates the downstream Nrf2/SLC7A11/GPX4 pathway in both the in vivo and in vitro models. Mangiferin failed to restore the osteoporosis and ferroptosis in Nrf2-knockout mice. Silencing Nrf2, SLC7A11 or GPX4 abolished the anti-ferroptosis effect of mangiferin in erastin-induced cells. Addition of the ferroptosis agonist RSL-3 also blocked the protective effects of mangiferin on iron-overloaded cells. Furthermore, mangiferin had better effects on osteogenesis than the ferroptosis inhibitor (ferrostatin-1) and the Nrf2 agonists (sulforaphane, dimethyl fumarate, and bardoxolone). CONCLUSIONS: We identify for the first time mangiferin as a ferroptosis inhibitor and a direct Keap1 conjugator that promotes bone formation and alleviates osteoporosis. This work also provides a potentially practical pharmacological approach for treating ferroptosis-driven diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2FerroptosisXanthonesFemaleAnimalsMiceKelch-Like ECH-Associated Protein 1Phospholipid Hydroperoxide Glutathione PeroxidaseDextransMice, KnockoutIron

Stichwörter der Autor:innen

FerroptosisGPX4MangiferinOsteoblastOsteoporosisSLC7A11

Substanzen

Kelch-Like ECH-Associated Protein 1Phospholipid Hydroperoxide Glutathione PeroxidasemangiferinNF-E2-Related Factor 2DextransIronKeap1 protein, mouseXanthones

Autor:innen und Institutionen

  • School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 311402, China.
  • Department of Medicine, Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang 310007, China.
  • School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 311402, China; Department of Medicine, Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang 310007, China. Electronic address:…

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Deng, X., Lin, B., Wang, F., Xu, P., & Wang, N. (2024). Mangiferin attenuates osteoporosis by inhibiting osteoblastic ferroptosis through Keap1/Nrf2/SLC7A11/GPX4 pathway. Phytomedicine, 124, 155282. https://doi.org/10.1016/j.phymed.2023.155282

Vancouver

Deng X, Lin B, Wang F, Xu P, Wang N. Mangiferin attenuates osteoporosis by inhibiting osteoblastic ferroptosis through Keap1/Nrf2/SLC7A11/GPX4 pathway. Phytomedicine. 2024;124:155282. doi:10.1016/j.phymed.2023.155282

BibTeX
@article{Deng2024,
  author = {Deng, Xuehui and Lin, Bingfeng and Wang, Fang and Xu, Pingcui and Wang, Nani},
  title = {Mangiferin attenuates osteoporosis by inhibiting osteoblastic ferroptosis through Keap1/Nrf2/SLC7A11/GPX4 pathway},
  journal = {Phytomedicine},
  year = {2024},
  volume = {124},
  pages = {155282},
  doi = {10.1016/j.phymed.2023.155282}
}
Kostenlos starten →